EU finalizes deal with Pfizer-BioNTech for 1.8 billion doses
How Wellcome’s opaque fossil fuel investments harm its global health mission
20 May 2021Study explores risk of developing long term conditions during the post-acute phase of COVID-19
20 May 2021EU finalizes deal with Pfizer-BioNTech for 1.8 billion doses
The European Union’s executive arm on Thursday finalized a third vaccine contract with Pfizer and BioNTech through 2023 for an additional 1.8 billion doses of their COVID-19 shot.
